← Browse by Condition
Medical Condition

kidney failure

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06889948 Phase 2
Recruiting

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Enrollment
30 pts
Location
Finland
Sponsor
Helsinki University Central Ho...
View Trial →
NCT07053462 Phase 1, Phase 2
Recruiting

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Enrollment
90 pts
Location
China
Sponsor
AMERICAN ORGAN TRANSPLANT AND ...
View Trial →